Sort
48,018 grants matching “immunotherapy”
Imaging Modulation of Immune Phenotype
$669,526Katherine W Ferrara · Stanford University · R01 · FY2021 · CA
A Novel Regulator of Antitumor Immunity and Immunotherapy
$669,506Rong Li · George Washington University · R01 · FY2024 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$669,492Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$669,436Dung T Le · Johns Hopkins University · P01 · FY2025 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$669,436Dung T Le · Johns Hopkins University · P01 · FY2021 · CA
MICRORNA REGULATION OF ADIPOSE TISSUE IMMUNE RESPONSE IN OBESITY
$669,251Huaizhu Wu · Baylor College Of Medicine · R01 · FY2025 · DK
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
$669,143Maria A Kukuruzinska · Boston University Medical Campus · R01 · FY2023 · DE
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$669,060Mark Larche · Mcmaster University · U19 · FY2014 · AI
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$669,048Mark Larche · Mcmaster University · U19 · FY2015 · AI
Ten-Fold Resolution Boost for Magnetic Particle Imaging with Applications to Rapid, Non-Invasive Imaging of CAR-T Cell Therapies, Stroke, GI Bleeds and Pulmonary Embolisms
$668,938Steven M Conolly · University Of California Berkeley · U01 · FY2025 · EB
Evaluation of novel treatments in biochemically recurrent prostate
$668,924Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$668,910Albert Folch · University Of Washington · R01 · FY2023 · CA
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$668,834Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Developing Tolerance Approaches to Overcome Humoral Immunity
$668,725Stuart Johnston Knechtle · Emory University · U19 · FY2012 · AI
Dynamics, Regulation and Function of p53 in Single Cells
$668,716Galit Lahav · Harvard Medical School · R35 · FY2022 · GM
A Novel Intervention Strategy for Stroke with RTL Therapy
$668,668Halina Offner · Virogenomics, Inc. · R42 · FY2013 · NS
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$668,650Ming You · Methodist Hospital Research Institute · R01 · FY2022 · CA
Role of gamma/delta T cells in Vaccine Induced Immunity
$668,643Daniel F. Hoft · Saint Louis University · R01 · FY2016 · AI
Clinical Protocol and Data Management (Core 018)
$668,602Elizabeth C Dees · Univ Of North Carolina Chapel Hill · P30 · FY2019 · CA
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
$668,588Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$668,570Shabaana A. Khader · Washington University · R01 · FY2019 · AI
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$668,565Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2025 · CA
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$668,450John H Sampson · Duke University · P01 · FY2019 · CA
Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Control of the immune response for cancer vaccine development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA